Mitochondrial proton leakage may make kidney transport consume oxygen inefficiently
After sodium–glucose cotransporter 2 (SGLT2) blockade, proton leakage may raise the oxygen cost of transport in downstream kidney cells. Normal proton conductance and adenosine triphosphate (ATP) output despite persistent oxygen shortage would reject this hypothesis.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Metabolism and energy
Mitochondrial proton leak
Proton passage across the inner mitochondrial membrane that increases oxygen consumption relative to ATP production
Where this hypothesis actsMitochondria of vulnerable downstream renal tubular cells after SGLT2 blockade
Hypotheses on this target 1
Inhibition1
Activation
Function preservation
Supplementation
Feedback restoration
Direct measurement
What is proposed
Inhibition
Reduce excess proton leak to restore coupling of respiration and ATP synthesis
With whatNot stated in the record
HowCorrect the molecular source of the leak after identifying it, while preserving distal reabsorption; the specific intervention is not stated
Possible result
Possible restoration of tissue oxygenation and reserve, stabilization of SPV_9 and reduced renal contribution to decline
From the recordКоррекция установленного источника утечки восстанавливает тканевую оксигенацию и резерв при сохранённой дистальной реабсорбции.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Reducing work in one part of the kidney could leave another part less able to cope with demand. The unexpected move is to blame inefficient energy production: downstream cells might consume more oxygen for the same useful work. That explanation is a proposal generated by this pipeline, not a measured result.
- SGLT2 blockade changes the fuel and dissolved substances reaching downstream kidney cells.
- Those changes are proposed to make the inner mitochondrial membrane more permeable to protons.
- More protons bypass energy production, so oxygen consumption yields less ATP.
- The same transport work then requires more oxygen and is proposed to produce local oxygen shortage and reduced reserve.
- Correcting the source of leakage is predicted to restore oxygen availability and reserve while preserving downstream transport.
- Recovered kidney function is proposed to reduce its contribution to deterioration elsewhere in the body.
A waterwheel can receive plenty of water yet do little work if some water escapes through a side channel. Closing that channel could restore useful work without increasing the water supply.
Where the picture breaks: Oxygen is not the water passing through the leak: protons cross the membrane, while oxygen is consumed by the machinery that maintains the energy-driving difference across it. The picture also leaves out competing demands and restrictions on blood supply.
- Master questionstep 01 of 04
Aging processes may reinforce one another, so changing a shared cause could benefit several body systems at once.
Rests on: The goal explicitly seeks life-extension ideas that act on a shared cause of interacting aging processes.
Stated in the chain - Goal pillarstep 02 of 04
Restoring function across the body should come with limits on costs that appear later.
Rests on: The search for benefits across several systems is narrowed to the possibility that recovery carries delayed costs.
AssumptionThe pillar takes delayed costs of recovery as a relevant obstacle to broad benefit; the master question does not identify those costs or explain their origin.
- Gap questionstep 03 of 04
Kidney protection may not amount to recovery across the body if blocking SGLT2 reduces energy use early in the kidney's filtering tubes but leaves later regions short of oxygen and with less reserve, meaning less capacity to meet additional demand, despite comparable activity and body water balance.S2S3
Rests on: Regional oxygen loss makes a hidden downstream cost plausible. Physiological Reports (2021) reports lower oxygen pressure in small blood vessels of deeper kidney regions in diabetic rats treated with dapagliflozin, an SGLT2-blocking drug; it does not establish lost reserve or effects across body systems. American Journal of Physiology. Renal Physiology (2018) describes a rat-kidney model in which oxygen-consuming transport shifts toward an inner kidney region; a calculation does not establish the proposed delayed cost in a living organism.
Supported by literature - Hypothesisstep 04 of 04
Changes in locally available fuel and dissolved substances after SGLT2 blockade are proposed to increase proton leakage through the inner membrane of mitochondria, the cell structures that produce usable energy. Protons, positively charged hydrogen particles, would cross that membrane without producing the usual amount of adenosine triphosphate (ATP), the molecule cells use to power work. Ordinary transport would then cost more oxygen, and repairing the leak is predicted to restore oxygen availability and reserve.
Rests on: The preceding question supplies the problem of downstream oxygen shortage despite lower upstream energy costs. The hypothesis attributes that mismatch to less useful energy obtained from oxygen rather than solely to increased transport work, heat or reduced blood supply.
AssumptionThe specific causal premise is that the changed local conditions increase proton leakage in vulnerable downstream cells. Neither the preceding stage nor the screened evidence establishes that connection; this is the mechanism being proposed, not a finding. The predicted stabilization of SPV_9 cannot be interpreted because that measure is not defined in the supplied material.
What is carried, and what is not. The supplied sources speak to two parts of the proposed mechanism: redistribution of oxygen demand within the kidney and a possible association between mitochondrial leakage and oxygen shortage. For the latter, Diabetologia (2023) recounts earlier animal work after diabetes was induced; it does not show that SGLT2 blockade causes downstream leakage, and no supplied source establishes the proposed sequence through repair and benefits across body systems.
Where the reasoning is carried by something unstated · 2
- Goal pillar. The pillar takes delayed costs of recovery as a relevant obstacle to broad benefit; the master question does not identify those costs or explain their origin.
- Hypothesis. The specific causal premise is that the changed local conditions increase proton leakage in vulnerable downstream cells. Neither the preceding stage nor the screened evidence establishes that connection; this is the mechanism being proposed, not a finding. The predicted stabilization of SPV_9 cannot be interpreted because that measure is not defined in the supplied material.
How a result here could mislead · 3
- Oxygen consumption remaining after ATP synthase, the enzyme that makes ATP, is blocked could be mistaken for proton leakage even when some oxygen is being consumed outside mitochondria. What closes it: The specification requires subtraction of oxygen consumption outside mitochondria and a direct estimate of proton conductance, how readily protons cross the membrane, alongside membrane potential, the electrical difference across it, and ATP production. Remaining oxygen consumption alone cannot identify the proposed defect.
- Improved oxygen availability after a corrective treatment could be credited to repaired leakage when the treatment instead reduces transport work, lowers local temperature or improves blood supply by relieving pressure. What closes it: A causal rescue must demonstrate reduced leakage and improved ATP production per oxygen consumed while preserving downstream reabsorption, the return of filtered substances to the blood. Local temperature, blood supply and tissue pressure must also be assessed to separate the proposed route from the supplied rivals; the specification does not give a complete control plan for these alternatives.
- Failure of a proposed leak-correcting treatment could be read as rejection of the hypothesis even if the treatment never corrected the leak. Conversely, an undefined measure of reserve could allow an apparent rescue to depend on how success is chosen afterward. What closes it: The molecular source must first be identified, and the intervention must be shown to reduce its leakage. Reserve and SPV_9 require operational definitions and success criteria fixed before testing; these are absent from the supplied material.
What would make this wrong. Persistent downstream oxygen shortage together with normal proton conductance and normal ATP production per oxygen consumed under the specified matched conditions would reject the proposed leakage explanation. That observation would break this mechanism, while leaving the broader possibility of delayed kidney costs open.
What it would change. If the mechanism held, lower energy use in one kidney region would not by itself establish a benefit across the body: the efficiency of energy production downstream would also matter. The search for a shared route to longer life would then need to account for this possible delayed cost of restoring function. Even a successful kidney-level rescue would leave life extension, protection of other body systems and transfer to humans unestablished; the proposed test's species and duration are not supplied.
Sources read · 5
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. · Diabetologia · 2023
“Also Nordquist et al. measured a decrease of renal PO 2 and increase of renal QO 2 after the induction of diabetes, which was indicated to result from an increased oxygen utilization due to glomerular hyperfiltration and oxygen loss through mitochondrial leak respiration .”
Does not settle: Текст описывает данные после индукции диабета у животных. Он не устанавливает, что блокада SGLT2 изменяет местную субстратную или осмотическую нагрузку, повышает протонную утечку в нижележащих клетках, снижает выход АТФ или что восстановление сопряжения стабилизирует SPV_9.
Impact of sodium glucose linked cotransporter-2 inhibition on renal microvascular oxygen tension in a rodent model of diabetes mellitus. · Physiological reports · 2021
“By contrast, measurements in the deeper cortex and outer medulla (red light) demonstrated a significant reduction in P k O 2 in dapagliflozin treated diabetic rats (p=0.014).”
Does not settle: This rat study measures regional microvascular oxygen tension after dapagliflozin; it does not establish altered mitochondrial proton leak, ATP yield, transport-work efficiency, vulnerable downstream cells, SPV_9, or intersystem effects.
SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolism. · American journal of physiology. Renal physiology · 2018
“A proposed shift in oxygen-consuming active transport to the outer medulla, which may simulate systemic hypoxia and enhance erythropoiesis, was also preserved with nephron loss.”
Does not settle: Источник описывает расчётную модель почки крысы. Он не устанавливает, что ингибирование натрий-глюкозного котранспортера 2 (SGLT2) повышает протонную проводимость внутренней мембраны митохондрий, уменьшает выход АТФ, влияет на SPV_9 или что восстановление сопряжения дыхания и синтеза АТФ уменьшает межсистемное ухудшение.
Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial. · EClinicalMedicine · 2021
“There were no differences between dapagliflozin and placebo twelve hours after intervention in measurements of baroreflex sensitivity, blood oxygen saturation or peripheral blood mononuclear cell mitochondrial oxygen consumption rate in presence of glucose ( ) or in inflammation biomarkers (Table S1).”
Does not settle: This acute study did not measure proton leak, membrane conductance, ATP coupling, or transport cost in renal downstream cells; its mitochondrial measurements were in peripheral blood mononuclear cells.
Iron, ESA, and HIF-Inhibitors: Are There Other Opportunities to Improve Anemia of CKD? · Journal of clinical medicine · 2026
“Experimental work and modelling indicate that this redistribution increases oxygen demand and lowers oxygen tension in the deep cortex and outer medulla [ ]—providing a localized hypoxic stimulus that upregulates renal erythropoietin synthesis and drives erythropoiesis.”
Does not settle: Источник не устанавливает увеличение протонной утечки через внутреннюю мембрану митохондрий, снижение выхода аденозинтрифосфата, восстановление сопряжения дыхания и синтеза АТФ или влияние на SPV_9.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Would oxygen shortage and lost spare kidney capacity during sugar-reabsorption blockade undermine claims of whole-body recovery?
Original wording · exactly as the pipeline generated it
Опровергнет ли перенос почечной защиты на системное восстановление обнаружение дистальной гипоксии и потери резерва при блокаде SGLT2, если проксимальные энергозатраты снижены, а активность и водный баланс сопоставимы?
What this question is asking
The question asks whether a treatment that protects the kidneys could still leave hidden weaknesses that limit recovery across the body. The treatment blocks sodium–glucose cotransporter 2 (SGLT2), a protein that returns filtered sugar and sodium from kidney tubules to the blood. It asks whether oxygen shortage in later tubule sections and reduced spare kidney capacity would undermine claims of whole-body recovery, even if earlier sections use less energy and physical activity and water balance are comparable between treated and comparison conditions. The intended comparison concerns recovery of kidney blood supply and waste removal over minutes to hours after combined demands, and whether repeated demands preserve spare capacity and stable internal conditions; the supplied material does not specify those demands or acceptable limits.
- Sodium–glucose cotransporter 2 (SGLT2) blockade
- Inhibition of a protein that helps return filtered glucose, a sugar, together with sodium, a salt component, from early kidney tubule sections to the blood. This is the intervention whose consequences for workload and recovery are being questioned.
- Kidney tubule and filtering unit
- A kidney filtering unit, also called a nephron, includes a filter and a tubule that processes the filtered fluid. Reabsorption means returning substances from that fluid to the blood.
- Proximal and distal tubule sections
- Proximal refers to earlier sections along the tubule, and distal to sections farther along it. The question asks whether reduced work early on could coexist with oxygen shortage farther along; these positions are not interchangeable with outer and inner kidney regions.
- Kidney cortex and medulla
- The cortex is the outer kidney region, and the medulla is the inner region. The supplied sources report or predict different oxygen-related responses in these regions.
- Hypoxia
- Insufficient oxygen availability in tissue. Oxygen consumption describes how much oxygen is used, so an increase in consumption alone does not establish hypoxia.
- Tubule workload and energy expenditure
- Workload is the transport work performed while processing filtered fluid; energy expenditure is the energy used to perform that work. The supplied model addresses oxygen consumed for transport, which does not establish every aspect of energy expenditure under the question's conditions.
- Kidney protection
- A broad description of beneficial kidney effects. It does not name one measurement and cannot, by itself, establish preserved oxygen conditions, spare capacity, and recovery across the body.
- Kidney functional reserve
- The kidney's spare capacity to increase function when demands rise. It concerns a response to demand, rather than merely the filtration rate measured at one time.
- Kidney perfusion, blood flow, and filtration rate
- Perfusion describes blood delivery through kidney tissue, blood flow describes the amount of blood moving through the kidney, and filtration rate describes how quickly fluid is filtered from blood. These are related but distinct measurements, and none alone measures all waste removal or spare capacity.
- Magnetic resonance imaging
- An imaging method used in the supplied clinical study to assess kidney function and oxygen-related changes. Its reported measurements do not themselves establish whole-body recovery.
- Dapagliflozin and empagliflozin
- Two drugs that inhibit sodium–glucose cotransporter 2. They are the treatments studied in the supplied clinical findings, which come from different populations and conditions.
- Sitagliptin
- The comparison drug in S6. That study's reported differences are relative to sitagliptin, rather than automatically describing a comparison with no treatment.
- Type 1 and type 2 diabetes
- Different diseases involving impaired regulation of blood sugar. They identify distinct populations in the supplied clinical studies, so findings from one do not automatically establish outcomes in the other.
- Albuminuria
- The presence of albumin, a blood protein, in urine. It is a characteristic of the population studied in S2.
- Water balance
- The relationship between water entering, leaving, and being retained in the body. Comparable water balance is a condition of the question, but is not established in the supplied findings.
- Systemic or whole-body recovery
- Recovery across the body, extending beyond an isolated kidney benefit. The supplied question links it to recovery after combined demands and preservation of stable internal conditions, but provides no complete measurement definition.
- Mathematical model
- A representation of biological processes used to calculate predicted outcomes. S3 concerns a rat filtering unit, so its predictions remain distinct from measured outcomes in people.
- Study protocol
- A description of how a study is planned. S8 describes work on transplanted kidneys, meaning kidneys placed into recipients, but reports no results.
SGLT2 blockade provides kidney protection and reduces proximal energy expenditure, leaving unresolved whether it reduces overall burden or shifts it into a vulnerable region when activity and water balance are comparable.
The assumption concerns a drug that reduces the return of filtered sugar and sodium to the blood in the early sections of the kidney's filtering units. It treats those sections as doing less energy-consuming work and asks whether established kidney protection consequently extends to recovery across the body. Comparable physical activity and water balance are conditions intended to separate the treatment's effects from differences in bodily demands or fluid conditions; they are not reported observations in the supplied evidence.
S1 establishes the reabsorption-blocking action, S3 predicts lower oxygen consumption for transport in the kidney's outer region, and S5 attributes improved oxygen availability to reduced tubule workload. These support a narrower workload-and-oxygen rationale, but do not establish reduced early-tubule energy expenditure under the question's specified conditions. S6 reports increased oxygen shortage in the inner kidney region, so the pipeline's suggestion that regional oxygen consequences remain entirely unexamined is too broad. None of these excerpts establishes the proposed extension from kidney protection to whole-body recovery, or the required comparability of activity and water balance.S1S3S5S6
The same question asked without the part nothing read establishes:
- During blockade of kidney sugar reabsorption, are oxygen shortage in later tubule sections and reduced spare kidney capacity associated with poorer whole-body recovery when activity and water balance are comparable?
- Does blockade of kidney sugar reabsorption improve recovery of blood supply and waste removal after repeated combined demands while preserving spare kidney capacity?
- The findings undermine the extension If the treatment causes local oxygen shortage and loss of spare kidney capacity under the stated comparable conditions, reduced work in early tubule sections would coexist with a functional limitation elsewhere. That would undermine using kidney protection alone as evidence of whole-body recovery, without establishing that every kidney benefit has disappeared.
- The findings coexist with preserved recovery If the regional oxygen shortage and reduced spare capacity coexist with preserved recovery under the specified demands, those findings alone would not refute that bounded recovery outcome. They would still limit any stronger claim that protection includes preservation of spare kidney capacity.
- The findings do not establish either conclusion If oxygen changes are measured without establishing spare capacity or recovery, the link from a regional change to failure of whole-body recovery remains missing. Neither successful recovery nor its failure follows from those measurements alone.
Blocking sugar and sodium reabsorption changes the work performed within the kidney, and a supplied model predicts that oxygen use falls in one region while rising in another [S1, S3]. If local oxygen availability cannot meet local demand, a reduction in work elsewhere would not establish protection of every kidney region. If that shortage also reduced spare kidney capacity, apparently adequate function at rest could coexist with poorer recovery when demands rise; this is the conditional reasoning behind the question, not a demonstrated finding. Treating kidney protection as proof of whole-body recovery could therefore overlook a limitation, while treating any regional oxygen change as proof that all benefits disappear would exceed the supplied evidence.
Узел RL-3 описывает защиту при хронической болезни почек; региональная гипоксия и последствия повышенной активности в целевом режиме остаются непроверенными.
При сочетанной нагрузке почечное кровоснабжение и выведение восстанавливаются за минуты и часы; повторения сохраняют резерв и внутреннюю среду в заданных пределах.
Клиническая органная польза не устанавливает, снижает ли вмешательство общую нагрузку после восстановления активности или переносит её в скрытый уязвимый участок.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Изменение местной субстратной и осмотической нагрузки после блокады SGLT2 увеличивает протонную утечку во внутренней мембране митохондрий уязвимых нижележащих клеток. Кислород расходуется при уменьшенном выходе аденозинтрифосфата (АТФ), поэтому даже обычная транспортная работа становится чрезмерно дорогой. Субстрат нарушения представляет повышенная протонная проводимость мембраны. Восстановление сопряжения дыхания и синтеза АТФ должно стабилизировать SPV_9 и уменьшить почечный вклад в межсистемное ухудшение.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
В выделенных нижележащих сегментах при одинаковых температуре, кислороде и субстратах сохраняются повышенное дыхание после блокирования синтеза АТФ, увеличенная протонная утечка и сниженное отношение синтеза АТФ к потреблению кислорода. Коррекция установленного источника утечки восстанавливает тканевую оксигенацию и резерв при сохранённой дистальной реабсорбции. Нормальная кривая протонной проводимости и нормальный выход АТФ при устойчивой гипоксии отвергают гипотезу.
Would tell it apart from at least one rival. The prediction states measurable physiological outcomes under matched conditions, a response to correction of the leak source, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Респирометрия, определение мембранного потенциала и скорости синтеза АТФ доступны для микродиссектированных канальцев. Дыхание после блокирования АТФ-синтазы необходимо дополнить оценкой протонной проводимости и вычитанием немитохондриального потребления кислорода. Причинная коррекция потребует сначала установить молекулярный источник утечки.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
В выделенных нижележащих сегментах при одинаковых температуре, кислороде и субстратах сохраняются повышенное дыхание после блокирования синтеза АТФ, увеличенная протонная утечка и сниженное отношение синтеза АТФ к потреблению кислорода. Коррекция установленного источника утечки восстанавливает тканевую оксигенацию и резерв при сохранённой дистальной реабсорбции. Нормальная кривая протонной проводимости и нормальный выход АТФ при устойчивой гипоксии отвергают гипотезу.
- What would separate them
Local heat buildup may raise oxygen demand and cause hypoxia in the aging kidney predicts: Повышение температуры мозгового вещества относительно артериальной крови предшествует падению тканевого парциального давления кислорода. Удержание местной температуры на уровне контрольной почки устраняет дополнительное потребление кислорода, гипоксию и потерю резерва при сохранённых дистальной доставке натрия, реабсорбции, давлении в канальцах и доставке кислорода. После приведения изолированных клеток обеих групп к одинаковой температуре эффективность митохондрий совпадает. Отсутствие температурного градиента достаточной величины отвергает эту гипотезу в пользу соперников.
- What would separate them
Shifting kidney transport work may deprive neighboring tubules of shared oxygen predicts: При одинаковых температуре, митохондриальной эффективности и микрососудистой геометрии увеличение реабсорбции в одном участке ухудшает оксигенацию соседнего участка, использующего тот же источник кислорода. Селективное уменьшение работы первого участка восстанавливает кислород и функцию второго. Эффект зависит от пространственного соседства и сохраняется при одинаковой общей доставке кислорода почке. Отсутствие такого соседского эффекта при подтверждённом изменении потребления отвергает модель локальной конкуренции.
- What would separate them
Fluid-driven tubule expansion may compress kidney vessels and reduce oxygen supply predicts: Расширение канальцев и уменьшение диаметра соседних сосудов предшествуют гипоксии. При одинаковых фильтрации, реабсорбции, температуре и артериальном давлении контролируемое снижение местного гидростатического давления восстанавливает капиллярный кровоток, кислород и повторный резерв. В изолированных клетках потребление кислорода на единицу транспорта и митохондриальная эффективность остаются нормальными. Сохранение гипоксии после подтверждённого устранения компрессии отвергает эту гипотезу.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.